MarketCap
Facebook
X
TelegramAnnual report 2022
added 07-25-2022
Taro Pharmaceutical Industries Ltd. Total Inventories 2011-2026 | TARO
Annual Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210 M | 180 M | 153 M | 148 M | 145 M | 141 M | 139 M | 120 M | 118 M | 110 M | 110 M | 107 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 210 M | 107 M | 140 M |
Quarterly Total Inventories Taro Pharmaceutical Industries Ltd.
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 180 M | - | - | - | 153 M | - | - | - | 148 M | - | - | - | 145 M | - | - | - | 141 M | - | - | - | 139 M | - | - | - | 120 M | - | - | - | 118 M | - | - | - | 110 M | - | - | - | 110 M | 107 M | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 180 M | 107 M | 134 M |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AbCellera Biologics
ABCL
|
6.34 M | $ 3.44 | -4.32 % | $ 1.03 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K |  USA |
 |
ADMA Biologics
ADMA
|
206 M | $ 15.36 | -2.17 % | $ 3.66 B | USA |
 |
Apellis Pharmaceuticals
APLS
|
143 M | $ 20.28 | 0.65 % | $ 2.56 B | USA |
 |
Aptorum Group Limited
APM
|
39.1 K | $ 0.79 | -1.15 % | $ 4.31 M |  China |
 |
Autolus Therapeutics plc
AUTL
|
4.14 M | $ 1.51 | 1.35 % | $ 385 M |  Britain |
 |
China SXT Pharmaceuticals
SXTC
|
828 K | $ 2.01 | -1.36 % | $ 2.86 M | China |
 |
Anika Therapeutics
ANIK
|
46.4 M | $ 14.05 | -1.44 % | $ 206 M | USA |
 |
ANI Pharmaceuticals
ANIP
|
137 M | $ 74.36 | -1.64 % | $ 1.44 B | USA |
 |
AVEO Pharmaceuticals
AVEO
|
1.66 M | - | - | $ 521 M | USA |
 |
Axsome Therapeutics
AXSM
|
27.9 M | $ 162.43 | 0.6 % | $ 8.08 B | USA |
 |
BioCryst Pharmaceuticals
BCRX
|
31.3 M | $ 8.49 | -0.18 % | $ 1.75 B | USA |
 |
BridgeBio Pharma
BBIO
|
26.8 M | $ 65.66 | -0.78 % | $ 12.6 B | USA |
 |
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | USA |
 |
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Berkeley Lights
BLI
|
18.9 M | - | -7.31 % | $ 87 M | USA |
 |
BioMarin Pharmaceutical
BMRN
|
1.3 B | $ 61.3 | 1.21 % | $ 11.8 B | USA |